Switch to:
Valeant Pharmaceuticals International Inc  (NYSE:VRX) Cash Flow from Others: $1,566 Mil (TTM As of Jun. 2017)

Valeant Pharmaceuticals International Inc's cash flow from others for the three months ended in Jun. 2017 was $-168 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Jun. 2017 was $1,566 Mil.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Valeant Pharmaceuticals International Inc Annual Data

Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Cash Flow from Others Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 293.10 738.50 293.00 766.00 1,810.00

Valeant Pharmaceuticals International Inc Quarterly Data

Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Cash Flow from Others Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.60 1,103.50 645.40 -15.00 -168.00

Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Jun. 2017 was 1103.5 (Sep. 2016 ) + 645.4 (Dec. 2016 ) + -15 (Mar. 2017 ) + -168 (Jun. 2017 ) = $1,566 Mil.


Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK